Kidney cancer: Tracking and therapy selection using ctDNA.

doi:10.1038/nrurol.2017.66

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Kidney cancer: Tracking and therapy selection using ctDNA.

Nature reviews. Urology - 1 Jul 2017

Fenner Annette

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Renal Cell
Share to Circulating Tumor DNA
Share to Kidney Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Source

Open in PubMed

Identifiers

PMID: 28467397
DOI: 10.1038/nrurol.2017.66

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Kidney cancer: Tracking and therapy selection using ctDNA.PMID 28467397Read ↗

TRACERx Renal: tracking renal cancer evolution through therapy.Semantic proximity Read ↗

Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Semantic proximity Read ↗

Kidney cancer: Classifying the unclassified - molecular analysis of uRCC.Semantic proximity Read ↗

SnapShot: Renal Cell Carcinoma.Semantic proximity Read ↗

Kidney cancerSemantic proximity Read ↗

Lung cancer: Using ctDNA to track EGFR and KRAS mutations in advanced-stage disease.Semantic proximity Read ↗

An overview of renal cell cancer: Pathology and geneticsSemantic proximity Read ↗

Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current LiteratureSemantic proximity Read ↗

Third-Line Treatment Options for Kidney Cancer.Semantic proximity Read ↗

Practical recommendations for using ctDNA in clinical decision makingSemantic proximity Read ↗

New data confirm clinical utility of ctDNA.Semantic proximity Read ↗

Detecting circulating tumor DNA in renal cancer: An open challengeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.